← brief for 2026-10-11 · Slowing decline

Collapsing Focal Segmental Glomerulosclerosis Progression to ESRD Following Combination Therapy with Pembrolizumab and Enfortumab Vedotin: A Case Report

Key takeaways

This is a report on one person who had kidney failure after cancer drugs. It is a preprint, so it has not passed peer review yet. It describes a rare side effect. It is not a large study, so it does not prove a general rule.

Who did this work

Hitti G · Gee C · Zuckerman J · Hanna R

Source

Preprint · Europe PMC, CKD · 2026-10-11
https://doi.org/10.21203/rs.3.rs-10936687/v1